{
  "ptid_time": "009_S_4337_2011-11-07",
  "img_path": "/data/qiuhui/data/adni/images/009_S_4337/2011-11-07/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 51,722 mm³, 34.3% above the reference mean. With a Z-score of 0.82 (79.4th percentile), this represents normal volume ; hippocampal volume measures 7,918 mm³, 4.7% above the reference mean. With a Z-score of 0.46 (67.8th percentile), this represents normal volume ; whole brain volume measures 997,391 mm³, 7.6% below the reference mean. With a Z-score of -0.99 (16.2th percentile), this represents normal volume ; entorhinal cortex volume measures 4,658 mm³, 13.6% above the reference mean. With a Z-score of 0.92 (82.2th percentile), this represents normal volume ; fusiform gyrus volume measures 17,276 mm³, 8.3% below the reference mean. With a Z-score of -0.71 (24.0th percentile), this represents normal volume ; middle temporal gyrus volume measures 22,624 mm³, 6.0% above the reference mean. With a Z-score of 0.54 (70.6th percentile), this represents normal volume . ",
  "text_data": "Age is 72.0 years. Gender is Male. Education: 12 years. Handedness: Right. Race: White. Medical history: Head, Eyes, Ears, Nose and Throat; Dermatologic-Connective Tissue; Endocrine-Metabolic; Renal-Genitourinary; Major Surgical Procedures. MMSE: 26.0. MoCA: 22.0. Logical Memory: 11.0. Laboratory findings: Total Bilirubin: 0.80 (significant elevated); Triglycerides (GPO): 273.00 (significant elevated); Cholesterol (High Performance): 275.00 (significant elevated). APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.01 SUVR (normal ); Amyloid beta: 998.60 pg/mL (normal ); Total tau: 114.20 pg/mL (moderate reduced); Phosphorylated tau: 9.90 pg/mL (moderate reduced). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The brain volume measurements are largely within normal ranges, with no significant atrophy in key regions like the hippocampus or entorhinal cortex. The MMSE (26) and MoCA (22) scores suggest mild cognitive impairment (MCI), but the absence of amyloid pathology (Aβ normal) and APOE4 reduces the likelihood of Alzheimer's disease. Reduced T-tau and P-tau are atypical for AD but may suggest another etiology.  \n\n**Diagnosis:** **MCI** (likely non-amyloid/non-AD subtype)  \n**Confidence:** **Medium** (due to conflicting biomarker patterns and normal structural imaging)",
  "timestamp": "2025-07-25T22:19:06.918856"
}